2639 Results

People

  1. Zelenetz
    Zelenetz
  2. Horwitz
    Horwitz
  3. Palomba
    Palomba
  4. Noy
    Noy
  5. Moskowitz
    Moskowitz
  6. Younes
    Younes
  7. Matasar
    Matasar
  8. Moskowitz
    Moskowitz
  9. Yahalom
    Yahalom
  10. Portlock
    Portlock

Groups

  1. Center for Hematologic Malignancies (2639)
  2. Department of Medicine (2639)
  3. Hematologic Malignancies, Division of (2639)
  4. Lymphoma (2639)
  5. Population Sciences Research Program (720)
  6. Survivorship Research (633)
  7. Executive Committee, Center for Hematologic Malignancies (389)
  8. Epidemiology and Biostatistics (363)
  9. GSK Faculty (356)
  10. Department of Pathology and Laboratory Medicine (300)
  1. "Lymphoma"
Formats
  1. Meeting Abstract (1340)
  2. Journal Article (1048)
  3. Book Section (63)
  4. Review (63)
  5. Editorial (37)
  6. Research Letter (35)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2639)
  2. Department of Medicine (2639)
  3. Hematologic Malignancies, Division of (2639)
  4. Lymphoma (2639)
  5. Population Sciences Research Program (720)
  6. Survivorship Research (633)

More Groups

People
  1. Andrew Zelenetz (767)
  2. Steven Horwitz (645)
  3. Maria Palomba (415)
  4. David Straus (356)
  5. Ariela Noy (351)
  6. Alison Moskowitz (339)

More People

Years
  1. 2025 (28)
  2. 2024 (100)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (833)
  2. Journal of Clinical Oncology (274)
  3. Hematological Oncology (110)
  4. Leukemia and Lymphoma (81)
  5. British Journal of Haematology (79)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (898)
  2. American Society of Clinical Oncology (290)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (173)
  5. John Wiley & Sons (95)
  6. Nature Publishing Group (92)

More Publishers

Results (2639)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bortezomib (Bor) with rituximab (R), cyclophosphamide (C) and prednisone (P): Two dosing schedules of a novel phase I regimen in patients with relapsed/refractory indolent and mantle cell lymphomas
    Meeting Abstract

    Gerecitano, J.; Portlock, C.; Hamlin, P.; Moskowitz, C.; Noy, A.; Straus, D.; Zelenetz, A. D.; Schulman, P.; Dumitrescu, O.; O'Connor, O. A.
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • A placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T (ID-KLH) and GM-CSF following rituximab in patients with CD20+ follicular lymphoma
    Meeting Abstract

    Freedman, A. S.; Neelapu, S.; Nichols, C. R.; Robertson, M.; Djulbegovic, B.; Winter, J. N.; Gold, D.; Bender, J.; Stewart, M.; Ghalie, R. G.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network
    Journal Article

    LaCasce, A. S.; Kho, M. E.; Friedberg, J. W.; Niland, J. C.; Abel, G. A.; Rodriguez, M. A.; Czuczman, M. S.; Millenson, M. M.; Zelenetz, A. D.; Weeks, J. C.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Long-term cardiac and pulmonary complications of cancer therapy
    Journal Article

    Yahalom, J.; Portlock, C. S.
    Hematology/Oncology Clinics of North America (2008)

    Fulltext@MSK | Save
  • Treatment of follicular lymphoma: Current status
    Journal Article

    Tilly, H.; Zelenetz, A.
    Leukemia and Lymphoma (2008)

    Fulltext@MSK | Save
  • Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium Study 020
    Journal Article

    Spitzer, T. R.; Ambinder, R. F.; Lee, J. Y.; Kaplan, L. D.; Wachsman, W.; Straus, D. J.; Aboulafia, D. M.; Scadden, D. T.
    Biology of Blood and Marrow Transplantation (2008)

    Fulltext@MSK | Save
  • F-18 FDG uptake in subcutaneous panniculitis-like T-cell lymphoma
    Journal Article

    Ravizzini, G.; Meirelles, G. S. P.; Horwitz, S. M.; Grewal, R. K.
    Clinical Nuclear Medicine (2008)

    Fulltext@MSK | Save
  • Infectious disease associations in advanced stage, indolent lymphoma (follicular and nonfollicular): Developing a lymphoma prevention strategy
    Journal Article

    Portlock, C. S.; Hamlin, P.; Noy, A.; Chey, W.; Gaydos, C. A.; Palomba, L.; Schwartz, I.; Corcoran, S.; Rosenzweig, L.; Walker, D.; more...
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • A multicentre phase II clinical experience with the novel aza-epothilone Ixabepilone (BMS247550) in patients with relapsed or refractory indolent non-Hodgkin lymphoma and mantle cell lymphoma
    Journal Article

    O'Connor, O. A.; Portlock, C.; Moskowitz, C.; Straus, D.; Hamlin, P.; Stubblefield, M.; Dumitrescu, O.; Colevas, A. D.; Grant, B.; Zelenetz, A.
    British Journal of Haematology (2008)

    Fulltext@MSK | Save
  • Indolent primary cutaneous B-cell lymphoma: Experience using systemic rituximab
    Journal Article

    Morales, A. V.; Advani, R.; Horwitz, S. M.; Riaz, N.; Reddy, S.; Hoppe, R. T.; Kim, Y. H.
    Journal of the American Academy of Dermatology (2008)

    Fulltext@MSK | Save